SCYNEXIS to Participate in Guggenheim’s 6th Annual Biotechnology Conference

JERSEY CITY, N.J., Jan. 30, 2024 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced David Angulo, M.D., President and Chief Executive Officer, will present at Guggenheim’s 6^th Annual Biotechnology Conference on Wednesday, February 7 at 11:00 A.M. ET.

Read more at globenewswire.com